CAXTON CORP - Q3 2022 holdings

$53.2 Million is the total value of CAXTON CORP's 17 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 25.0% .

 Value Shares↓ Weighting
USO SellUNITED STS OIL FD LPcall$11,326,000
-60.1%
173,500
-50.9%
21.30%
-44.2%
SellARCELLX INC$1,430,000
-22.2%
76,186
-25.1%
2.69%
+8.8%
VECT SellVECTIVBIO HLDG AG$845,000
-19.6%
140,863
-27.6%
1.59%
+12.5%
GLD ExitSPDR GOLD TR$0-40,820
-100.0%
-9.24%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLECULAR TEMPLATES INC24Q2 202330.7%
STRONGBRIDGE BIOPHARMA PLC22Q3 202173.1%
BERKSHIRE HATHAWAY INC DEL20Q2 20245.8%
GARRISON CAP INC18Q3 20209.9%
EIGER BIOPHARMACEUTICALS INC17Q3 20221.7%
AGILE THERAPEUTICS INC16Q1 201855.5%
KALA PHARNACEUTICALS INC16Q4 202117.6%
CM FIN INC16Q1 20197.8%
SYNTA PHARMACEUTICALS CORP15Q2 201699.9%
REZOLUTE INC15Q2 202428.7%

View CAXTON CORP's complete holdings history.

Latest significant ownerships (13-D/G)
CAXTON CORP Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Savara IncFebruary 13, 2024353,4410.3%
SCYNEXIS INCSold outFebruary 13, 202400.0%
Addex Therapeutics Ltd.February 14, 2023718,8490.9%
Cardiff Oncology, Inc.February 14, 2023983,6072.2%
Rezolute, Inc.February 14, 20231,860,5185.0%
Xeris Biopharma Holdings, Inc.February 14, 20235,973,3244.4%
CTI BIOPHARMA CORPFebruary 14, 20222,239,3002.3%
Sierra Oncology, Inc.February 14, 20221,119,3227.0%
Strongbridge Biopharma plcSold outJanuary 05, 202200.0%
SUNESIS PHARMACEUTICALS INCSold outFebruary 16, 202100.0%

View CAXTON CORP's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-09-03
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14

View CAXTON CORP's complete filings history.

Compare quarters

Export CAXTON CORP's holdings